Medscape UK

• Atopic Eczema and Obesity: Is There a Link? This study found a small association between diagnosed atopic eczema and being overweight or obese.
  Medscape UK, October 28, 2020
• Corticosteroids for Asthma Could Increase Fracture Risk Exposure to oral corticosteroid (OCS) and inhaled corticosteroid (ICS) is an independent risk factor for bone health in patients with asthma.
  Medscape UK, October 27, 2020
• Vitamin D Deficiency May Be a Risk Factor for Depression in Middle-aged Adults Vitamin D deficiency (<20 nmoL/L) and insufficiency (20-50 nmoL/L) are associated with an increased risk of developing new-onset depression in middle-aged adults.
  Medscape UK, October 26, 2020
• Triple Therapy (LABA/LAMA/ICS) vs LABA/LAMA Combo for COPD In patients with chronic obstructive pulmonary disease (COPD), triple therapy (long-acting beta-adrenoceptor agonists [LABA]/long-acting muscarinic antagonists [LAMA]/inhaled corticosteroid [ICS]) was more effective in reducing moderate-to-severe exacerbations and mortality than LABA/LAMA combination.
  Medscape UK, October 23, 2020
• Quiz: Test Your Knowledge on Cancer Referrals for Children and Young Adults NICE has recently published guidance on suspected cancer, recognition and referral in children and young adults. Take our quiz to find out what you know.
  Medscape UK, October 22, 2020
• Ultra-processed Food Consumption and Obesity in the UK Diets rich in ultra-processed foods were associated with a 79% and 30% significant increase in the risk of obesity and abdominal obesity, respectively.
  Medscape UK, October 22, 2020
• TCT 2020 Four Top Trials From TCT 2020   Prof Mamas Mamas presents his pick of research presented at this year's virtual Transcatheter Cardiovascular Therapeutics (TCT) 2020.
  Medscape UK, October 22, 2020
• SGLT2is Lower Cardiorenal Risk in T2D Patients Without Cardiovascular and Renal Disease Sodium-glucose cotransporter-2 inhibitors (SGLT2is) use was associated with a lower risk of heart failure (HF) and chronic kidney disease (CKD) vs dipeptidyl peptidase-4 inhibitors (DPP4is) in type 2 diabetes (T2D) patients free from cardiovascular (CV) and renal disease (CVRD), managed in routine clinical practice.
  Medscape UK, October 20, 2020
• Thiopurine Monotherapy Effective in Ulcerative Colitis, But Less So in Crohn’s Disease Thiopurine monotherapy is an effective long-term treatment for ulcerative colitis (UC), but significantly less effective in Crohn’s disease (CD), particularly where there is perianal involvement.
  Medscape UK, October 19, 2020
• COVID-19 A&E Perspective: Iceberg Ahoy Dr Dan O'Carroll reflects on increasing pressures on emergency departments as COVID-19 cases rise.
  Medscape UK, October 16, 2020
• Cardiovascular Events and Mortality in Patients with T2D and Multimorbidity In patients with type 2 diabetes (T2D), level of multimorbidity, and in particular, cardiovascular disease (CVD) multimorbidity, was associated with an increased risk and early onset of a CVD event, mortality, and CV mortality.
  Medscape UK, October 16, 2020
• Excess Weight May Be a Risk Factor for Rheumatoid Arthritis in Women Higher body mass index (BMI) in middle age, BMI in early adulthood and waist circumference were associated with an increased risk of rheumatoid arthritis (RA).
  Medscape UK, October 15, 2020
• Switching to Sacubitril/Valsartan Improves Outcomes in Patients with HFrEF This real-world clinical practice data suggest that switching treatment to sacubitril/valsartan in optimally treated stable patients with heart failure with reduced ejection fraction (HFrEF) results in significant improvements in cardiac structure and function, quality of life, heart failure symptoms as assessed by the physician and functional capacity.
  Medscape UK, October 14, 2020
• DPP4is, GLP-1 Receptor Agonists Linked to Reduced Incidence of Parkinson’s Disease in T2D The incidence of Parkinson’s disease (PD) in patients with type 2 diabetes (T2D) varies substantially depending on the treatment received for diabetes.
  Medscape UK, October 13, 2020
• COVID-19: NICOR Report's Insights Into COVID and Cardiovascular Outcomes   Professor Mamas Mamas reflects on the first wave insights of the National Institute of Cardiovascular Outcomes Research (NICOR) report on COVID-19 patients with cardiovascular disease.
  Medscape UK, October 12, 2020
• Antibiotics for Respiratory Tract Infections in Down's Syndrome In children with Down's syndrome, the prescription of antibiotics following respiratory tract infection (RTI)-related general practitioner (GP) consultations did not reduce the overall risk of subsequent RTI-related hospitalisation.
  Medscape UK, October 12, 2020
• Topical Corticosteroid and Home-based Narrowband UVB for Localised Vitiligo Combination treatment with hand-held narrowband-ultraviolet B (NB-UVB) light and potent topical corticosteroid (TCS) is likely to result in improved treatment response in patients with localised non-segmental vitiligo compared with potent TCS alone.
  Medscape UK, October 09, 2020
• COVID-19: End of Life Care Concerns After Rise in Home Deaths There's been a significant rise in people dying at home since the COVID-19 pandemic started and that trend looks set to continue.
  Medscape UK, October 09, 2020
• Chronic Kidney Disease Correlates With Increased Risk of Tuberculosis Diagnosis This study found an increased risk of tuberculosis (TB) in patients with chronic kidney disease (CKD) not requiring renal replacement therapy compared with patients without CKD.
  Medscape UK, October 08, 2020
• Does Delaying Antibiotics for UTI in Over-65s Influence Risk of Bloodstream Infection? Delaying or withholding antibiotics for suspected lower urinary tract infection (UTI) did not increase the risk of bloodstream infection (BSI) in adults aged ≥65 years.
  Medscape UK, October 07, 2020